CanSino Biologics, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003F01
HKD
33.04
-0.78 (-2.31%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Weak Long Term Fundamental Strength with a -1.44% CAGR growth in Operating Profits over the last 5 years

  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -60.98
2

Risky -

3

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

HKD 4,439 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.28

stock-summary
Return on Equity

-2.94%

stock-summary
Price to Book

0.82

Revenue and Profits:
Net Sales:
412 Million
(Quarterly Results - Dec 2025)
Net Profit:
15 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-5.49%
0%
-5.49%
6 Months
-36.83%
0%
-36.83%
1 Year
-5.73%
0%
-5.73%
2 Years
91.2%
0%
91.2%
3 Years
-21.33%
0%
-21.33%
4 Years
-73.67%
0%
-73.67%
5 Years
-89.56%
0%
-89.56%

CanSino Biologics, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
174.56%
EBIT Growth (5y)
-1.44%
EBIT to Interest (avg)
-60.98
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.23
Sales to Capital Employed (avg)
0.09
Tax Ratio
1.16%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
25.84%
ROE (avg)
4.54%

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.21
EV to EBIT
-15.78
EV to EBITDA
-42.01
EV to Capital Employed
1.29
EV to Sales
5.02
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-8.17%
ROE (Latest)
-3.37%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 21.45% vs 28.17% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -51.80% vs 1,552.38% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "411.70",
          "val2": "339.00",
          "chgp": "21.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "21.30",
          "val2": "51.70",
          "chgp": "-58.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.50",
          "val2": "12.10",
          "chgp": "-71.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.40",
          "val2": "2.20",
          "chgp": "-118.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "14.70",
          "val2": "30.50",
          "chgp": "-51.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-73.20%",
          "val2": "1.40%",
          "chgp": "-7.46%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 28.45% vs 134.50% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 107.26% vs 80.86% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,148.90",
          "val2": "894.40",
          "chgp": "28.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "67.90",
          "val2": "-217.50",
          "chgp": "131.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "62.10",
          "val2": "65.20",
          "chgp": "-4.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.80",
          "val2": "-6.70",
          "chgp": "58.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "30.20",
          "val2": "-416.00",
          "chgp": "107.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-109.60%",
          "val2": "-502.20%",
          "chgp": "39.26%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
411.70
339.00
21.45%
Operating Profit (PBDIT) excl Other Income
21.30
51.70
-58.80%
Interest
3.50
12.10
-71.07%
Exceptional Items
-0.40
2.20
-118.18%
Consolidate Net Profit
14.70
30.50
-51.80%
Operating Profit Margin (Excl OI)
-73.20%
1.40%
-7.46%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 21.45% vs 28.17% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -51.80% vs 1,552.38% in Sep 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
1,148.90
894.40
28.45%
Operating Profit (PBDIT) excl Other Income
67.90
-217.50
131.22%
Interest
62.10
65.20
-4.75%
Exceptional Items
-2.80
-6.70
58.21%
Consolidate Net Profit
30.20
-416.00
107.26%
Operating Profit Margin (Excl OI)
-109.60%
-502.20%
39.26%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 28.45% vs 134.50% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 107.26% vs 80.86% in Dec 2024

stock-summaryCompany CV
About CanSino Biologics, Inc. stock-summary
stock-summary
CanSino Biologics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available